Suppr超能文献

在过去 10 年,在一家单中心,供者特征对 T 细胞完全清除的单倍体相合造血干细胞移植的影响。

Effect of donor characteristics on T cell-replete haploidentical stem cell transplantation over the last 10 years at a single institution.

机构信息

Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Institute of Hematology, Zhejiang University, Hangzhou, China.

出版信息

Br J Haematol. 2022 Mar;196(5):1225-1238. doi: 10.1111/bjh.17978. Epub 2021 Dec 3.

Abstract

One of the most complex issues with haploidentical stem cell transplantation (haplo-SCT) is donor selection, given that multiple haploidentical donors are often available for a given recipient. To develop evidence-based guidance for donor selection in the setting of anti-thymocyte globulin-based haplo-SCT, we performed a prospective cohort study of 512 patients with haematological malignancies who had haplo-SCT to determine which donor variables were most important in favouring transplant outcomes. Increasing donor age was associated with poorer overall survival (OS) [hazard ratio (HR) 1·08, P = 0·044]. Female donors to male recipients was significantly associated with higher non-relapse mortality (NRM; HR 2·05, P = 0·006). Furthermore, increasing donor age had a higher risk of Grades 3-4 acute graft-versus-host disease (aGVHD; HR 1·17, P = 0·005), female donors to male recipients was associated with a higher risk of Grades 2-4 aGVHD (HR 1·50, P = 0·022). Sibling donors had superior OS, disease-free survival, and NRM than parental donors in patients aged <35 years. However, sibling donors had higher NRM than offspring donors in patients aged ≥35 years. A younger donor, usually a young sibling in younger recipients (aged <35 years) or a young offspring in older patients (aged ≥35 years) and avoiding female donors to male recipients should be preferred when multiple haploidentical donors are available.

摘要

在单倍体造血干细胞移植(haplo-SCT)中,最复杂的问题之一是供体选择,因为对于给定的受者,通常有多个单倍体供体可供选择。为了为基于抗胸腺细胞球蛋白的haplo-SCT 背景下的供体选择制定基于证据的指南,我们对 512 例接受 haplo-SCT 的血液系统恶性肿瘤患者进行了前瞻性队列研究,以确定哪些供体变量对移植结果最为重要。供体年龄的增加与总生存(OS)较差相关(风险比[HR] 1.08,P=0.044)。女性供体给男性受者与非复发死亡率(NRM)显著增加相关(HR 2.05,P=0.006)。此外,供体年龄的增加与 3-4 级急性移植物抗宿主病(aGVHD)的风险更高相关(HR 1.17,P=0.005),女性供体给男性受者与 2-4 级 aGVHD 的风险更高相关(HR 1.50,P=0.022)。在年龄<35 岁的患者中,与父母供体相比,同胞供体具有更好的 OS、无病生存和 NRM。然而,在年龄≥35 岁的患者中,同胞供体的 NRM 高于后代供体。当有多个单倍体供体时,应选择较年轻的供体,通常是年轻的同胞在年轻的受者(年龄<35 岁)中,或年轻的后代在年龄较大的患者(年龄≥35 岁)中,避免女性供体给男性受者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验